The Genius Digital Diagnostics System, which blends novel artificial intelligence (AI) algorithms with advanced digital ...

SkylineDx today announced the launch of the Guideline-Informed Risk Assessment Initiative, a clinical program designed to support surgeons and multidisciplinary teams in evaluating patients with T1 ...

Insight Molecular Diagnostics completes major milestones to support GraftAssureDx test kit trial for in vitro diagnostic for US FDA submission: Nashville, Tennessee Thursday, Marc ...

The NASH Biomarkers Market sees major opportunities in non-invasive diagnostics combining serum markers, imaging, and AI for metabolic disease management. Key growth drivers include the demand for ...

Three-site reproducibility study completed by Tampa General Hospital, Mayo Clinic, and Baylor Scott & White HealthSufficient clinical samples ...

Sepsis and acute infection remain among the most challenging conditions in emergency and critical care, where high-stakes ...

Announced at SLAS 2026 in Boston, Synthace have partnered with Charles River Laboratories to advance assay development, combining software, automation and experimental design. The collaboration ...

Cofounding CEO Arnon Chait to remain with company as Chief Innovation Officer CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, has ...

Cofounding CEO Arnon Chait to remain with company as Chief Innovation Officer Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, has named Michael Iskra as its new ...

VolitionRx Limited (AMEX:VNRX) Q3 2025 Earnings Call Transcript November 14, 2025 Operator: Good morning, ladies and gentlemen, and thank you for standing by. Welcome to VolitionRx Limited Third ...

Biodesix, Inc., a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and ...